Showing results (2071-2080 of 3,277) with videos related to
Sort By:
Pageof 328
Clinical and Diagnostic Laboratory Immunology|February 10, 1998
Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virusH B Jenson, G M Grant, Y Ench, et al.Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 13, 2018
Work Related Post Traumatic Stress Disorder in Medicine ResidentsLakshmi Kannan, David S Wheeler, Scott Blumhof, et al.Journal of Pharmacological and Toxicological Methods|October 18, 2000
Use of a cell-based, lawn format assay to rapidly screen a 442,368 bead-based peptide libraryC K Jayawickreme, H Sauls, N Bolio, et al.Traffic (Copenhagen, Denmark)|February 24, 2001
A new functional domain of guanine nucleotide dissociation inhibitor (alpha-GDI) involved in Rab recyclingP Luan, A Heine, K Zeng, et al.Health Education & Behavior : the Official Publication of the Society for Public Health Education|February 28, 2019
Is There a Spillover Effect of Targeted Dietary Change on Untargeted Health Behaviors? Evidence From a Dietary Modification TrialElizabeth A Sarma, Anne Moyer, Catherine R Messina, et al.Clinical Pharmacology and Therapeutics|February 4, 2011
Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapyW Sadee, D Wang, A C Papp, et al.Journal of Hepatology|February 28, 2002
Emotional distress in chronic hepatitis C patients not receiving antiviral therapyRobert J Fontana, Khozema B Hussain, Steven M Schwartz, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 12, 2010
Exposure to cocaine dynamically regulates the intrinsic membrane excitability of nucleus accumbens neuronsPing Mu, Jason T Moyer, Masago Ishikawa, et al.Human Pathology|July 16, 2017
Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2J Kenneth Schoolmeester, Ann M Moyer, McKinsey L Goodenberger, et al.Pain Reports|February 3, 2018
TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group studyPrasarn Manitpisitkul, Michael Brandt, Christopher M Flores, et al.Pageof 328